Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs SANOFI INDIA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA SANOFI INDIA AUROBINDO PHARMA/
SANOFI INDIA
 
P/E (TTM) x 12.9 22.8 56.8% View Chart
P/BV x 1.1 6.1 18.3% View Chart
Dividend Yield % 1.9 8.5 22.4%  

Financials

 AUROBINDO PHARMA   SANOFI INDIA
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-22
SANOFI INDIA
Dec-21
AUROBINDO PHARMA/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs1,0649,300 11.4%   
Low Rs5847,344 8.0%   
Sales per share (Unadj.) Rs400.31,283.8 31.2%  
Earnings per share (Unadj.) Rs45.7410.1 11.1%  
Cash flow per share (Unadj.) Rs64.9439.0 14.8%  
Dividends per share (Unadj.) Rs9.00490.00 1.8%  
Avg Dividend yield %1.15.9 18.6%  
Book value per share (Unadj.) Rs419.4940.3 44.6%  
Shares outstanding (eoy) m585.9423.03 2,544.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.16.5 31.8%   
Avg P/E ratio x18.020.3 88.8%  
P/CF ratio (eoy) x12.719.0 66.9%  
Price / Book Value ratio x2.08.9 22.2%  
Dividend payout %19.7119.5 16.5%   
Avg Mkt Cap Rs m482,799191,661 251.9%   
No. of employees `000NANA-   
Total wages/salary Rs m34,5094,339 795.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m234,55529,566 793.3%  
Other income Rs m3,226746 432.4%   
Total revenues Rs m237,78130,312 784.4%   
Gross profit Rs m42,56612,515 340.1%  
Depreciation Rs m11,265667 1,688.9%   
Interest Rs m48618 2,702.2%   
Profit before tax Rs m34,04012,576 270.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7,2563,132 231.7%   
Profit after tax Rs m26,7849,444 283.6%  
Gross profit margin %18.142.3 42.9%  
Effective tax rate %21.324.9 85.6%   
Net profit margin %11.431.9 35.7%  
BALANCE SHEET DATA
Current assets Rs m181,22736,791 492.6%   
Current liabilities Rs m81,56022,908 356.0%   
Net working cap to sales %42.547.0 90.5%  
Current ratio x2.21.6 138.4%  
Inventory Days Days25189 13.3%  
Debtors Days Days6218 353.9%  
Net fixed assets Rs m155,10418,762 826.7%   
Share capital Rs m586230 254.7%   
"Free" reserves Rs m245,17421,425 1,144.3%   
Net worth Rs m245,76021,655 1,134.9%   
Long term debt Rs m2,4920-   
Total assets Rs m336,33155,553 605.4%  
Interest coverage x71.0699.7 10.1%   
Debt to equity ratio x00-  
Sales to assets ratio x0.70.5 131.0%   
Return on assets %8.117.0 47.6%  
Return on equity %10.943.6 25.0%  
Return on capital %13.958.2 23.9%  
Exports to sales %31.10-   
Imports to sales %11.919.4 61.6%   
Exports (fob) Rs m72,862NA-   
Imports (cif) Rs m27,9655,723 488.6%   
Fx inflow Rs m77,2453,856 2,003.2%   
Fx outflow Rs m31,5245,723 550.8%   
Net fx Rs m45,721-1,867 -2,448.9%   
CASH FLOW
From Operations Rs m50,1655,588 897.7%  
From Investments Rs m-32,1166,308 -509.1%  
From Financial Activity Rs m-29,693-8,490 349.7%  
Net Cashflow Rs m-11,6743,406 -342.7%  

Share Holding

Indian Promoters % 48.8 0.0 -  
Foreign collaborators % 3.1 60.4 5.1%  
Indian inst/Mut Fund % 38.0 26.5 143.1%  
FIIs % 21.4 8.3 259.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 39.6 121.6%  
Shareholders   358,459 73,734 486.2%  
Pledged promoter(s) holding % 15.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    PIRAMAL ENTERPRISES    


More on Aurobindo Pharma vs Sanofi India

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Aurobindo Pharma vs Sanofi India Share Price Performance

Period Aurobindo Pharma Sanofi India S&P BSE HEALTHCARE
1-Day 0.25% 0.95% -0.10%
1-Month -15.66% 1.93% -1.99%
1-Year -30.20% -27.25% -5.62%
3-Year CAGR 1.45% -7.13% 20.96%
5-Year CAGR -6.95% 5.54% 11.47%

* Compound Annual Growth Rate

Here are more details on the Aurobindo Pharma share price and the Sanofi India share price.

Moving on to shareholding structures...

The promoters of Aurobindo Pharma hold a 51.8% stake in the company. In case of Sanofi India the stake stands at 60.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Aurobindo Pharma and the shareholding pattern of Sanofi India.

Finally, a word on dividends...

In the most recent financial year, Aurobindo Pharma paid a dividend of Rs 9.0 per share. This amounted to a Dividend Payout ratio of 19.7%.

Sanofi India paid Rs 490.0, and its dividend payout ratio stood at 119.5%.

You may visit here to review the dividend history of Aurobindo Pharma, and the dividend history of Sanofi India.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Snaps 8-Day Winning Streak to End 416 Points Lower| Nifty Today Ends Below 18,700 | Auto and IT Stocks Drags(Closing)

After opening the day on a negative note, Indian share markets continued their momentum and ended the day 0.7% lower.